Tirzepatide-Hormone Therapy Combo Tied to Weight Loss in Postmenopausal Women



(MedPage Today) — ORLANDO — Postmenopausal women using hormone therapy (HT) saw significantly greater weight loss while taking the dual GIP/GLP-1 receptor agonist tirzepatide than their counterparts not using HT, according to a retrospective…



Source link : https://www.medpagetoday.com/meetingcoverage/tms/118146

Author :

Publish date : 2025-10-26 19:20:00

Copyright for syndicated content belongs to the linked Source.
Exit mobile version